MedPath

Effect of Local Anesthesia Versus Induced Hypotensive Anesthesia on Quality of External Dacryocystorhinostomy Operation

Not Applicable
Conditions
Patient With Nasolacrimal Duct Obstruction
External Dacryocystorhinostomy Operation
Interventions
Registration Number
NCT05241054
Lead Sponsor
Mansoura University
Brief Summary

Bleeding is one of the important complications during Dacryocystorhinostomy, which dissatisfy ophthalmic surgeon, reduces surgical field visualization, and increases the duration of surgery Thus, the management of this complication is a great consideration during this operation. The aim of this study is to compare the efficacy of combined local and general anesthesia in a group of patients undergoing external dacryocystorhinostomy (DCR) operation versus the efficacy of general anesthesia with induced hypotensive anesthesia

Detailed Description

Dacryocystorhinostomy or DCR is among the common oculoplastics surgeries performed for managing epiphora due to nasolacrimal duct obstruction. The main purpose of DCR surgery is to eliminate the obstruction and to accomplish normal tear. DCR is a procedure performed to drain the lacrimal sac in which lacrimal flow is diverted into the nasal cavity through an artificial opening made at the level of the lacrimal sac in cases of chronic dacryocystitis or symptomatic nasolacrimal duct obstruction not relieved by simple probing and stringing.

Dacryocystorhinostomy (DCR) operation can be performed externally or endoscopically. External DCR was first described by Toti and this procedure was modified with the use of flaps by many authors. It is the gold standard of treatment with a reported success rate of more than 90%.

Bleeding during dacryocystorhinostomy (DCR) is trivial, but because of the anatomical vessel variation and presence of tiny vessels in the field of DCR, it can obscure the surgical field and complicate the operation.

One of the effective approaches for controlling bleeding tendency during DCR is to reduce blood pressure in patients. Ideal hypotensive medications administered to reduce blood pressure should have specific features such as easy to administration, being with rapid onset and offset without side effects, rapid elimination without any toxic metabolites, and having a predictable and dose-dependent action. Nitroglycerine (TNG) is a direct vasodilator agent, especially in veins, and produces hypotension, and is preferred by clinicians because of rapid onset and offset time and easy titration.

Another mechanism for controlling bleeding is infiltrating the incision site by local anesthetic with admixed epinephrine to promote local vasoconstriction to decrease blood loss and prolong the duration of local anesthesia providing more time for analgesia.

In this study, the investigators will compare the efficacy of local versus induced hypotensive anesthesia in generally anesthetized patients undergoing external DCR operation on amount of blood loss, quality of the surgical field, intraoperative hemodynamics, and surgeon satisfaction

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
64
Inclusion Criteria
  • American Society of Anesthesiologists physical status I and II
  • patients who are scheduled for external Dacryocystorhinostomy operation
Exclusion Criteria
  • Patient refusal.
  • Patients with history for cerebrovascular.
  • Patients with history for coronary insufficiency.
  • Local skin infection at site of injection.
  • Known hypersensitivity to the study drugs.
  • Extremes of age.
  • Patients with any type of arrhythmias.
  • Hematological diseases.
  • Bleeding abnormality
  • Coagulation abnormality

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BupivacaineMechanical ventilationPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineHead-up tiltPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineParacetamolPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
NitroglycerineMechanical ventilationPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineHead-up tiltPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
BupivacaineLactated RingersPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineFentanylPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineBupivacainePatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacainePropofolPatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineAtracurium BesylatePatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
BupivacaineSevofluranePatients will receive local anesthesia by paranasal infiltration at the incision site with 2.5 ml of 0.5% bupivacaine with 1:100000 epinephrine.
NitroglycerineNitroglycerinePatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerinePropofolPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineFentanylPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineAtracurium BesylatePatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineSevofluranePatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineLactated RingersPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
NitroglycerineParacetamolPatients will receive an infusion of Nitroglycerine (TNG) (0.2-1μg/kg/min) will be started and adjusted to maintain mean arterial blood pressure between 55-65 mmHg.
Primary Outcome Measures
NameTimeMethod
Average category scale (ACS)after 10 min of maintaining mean arterial blood pressure (MAP) at the desired range (55-65 mmHg)

Assessment of intraoperative blood loss and quality of surgical field by Average category scale (ACS) for assessment of intraoperative surgical field (0-5): 0 - No bleeding 1 - Slight bleeding - no suctioning of blood required 2 - Slight bleeding 3- slight bleeding required suctioning 4- moderate bleeding 5- sever bleeding

Secondary Outcome Measures
NameTimeMethod
Mean arterial blood pressureprocedure (basal reading and every 5 minutes till the end of anesthesia )

Mean arterial blood pressure values will be recorded

Postoperative visual analogue score (VAS)up to 24 hours after the procedure

Pain levels will be assessed post operatively using visual analogue score (vas) at 0 min , 6 hour, 12hour , 24hours postoperatively .

Heart Rate (HR)procedure (basal reading and every 5 minutes till the end of anesthesia)

Heart Rat values will be recorded

Postoperative analgesics intakeup to 24 hours after the procedure

Total dose of ketorolac requirements will be recorded

Surgeon satisfactionat the end of the procedure

Surgeon satisfaction will be recorded based on a 4 points scale (1=bad, 2=moderate, 3=good, 4=excellent).

Hematomaup to 24 hours after the procedure

The patients will be evaluated postoperatively to identify the occurrence of hematoma (blood collection, swelling, bruises) at the site of injection of bupivacaine.

Nauseaup to 24 hours after the procedure

Postoperative Nausea will be assessed on a scale of 0 to 3 \[0; no nausea, 1, mild nausea, 2; moderate nausea, 3; severa nausea\]

Vomitingup to 24 hours after the procedure

Postoperative Vomiting will be assessed on a scale of 0 to 3 \[0; no vomiting, 1, mild vomiting, 2; moderate vomiting, 3; severe vomiting\]

Trial Locations

Locations (1)

Mansoura University

🇪🇬

Mansoura, DK, Egypt

© Copyright 2025. All Rights Reserved by MedPath